# Study Assessing Hybrid SPECT-CT With Labeled Leukocytes for Diagnosis of Vascular Prosthesis Infections

> **NCT02538133** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Angers** · enrollment: 80 (estimated)

## Conditions studied

- Vascular Prosthesis Infection

## Interventions

- **BIOLOGICAL:** 99mTc-Exametazime (HMPAO)-labeled leukocytes

## Key facts

- **NCT ID:** NCT02538133
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2019-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02538133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02538133, "Study Assessing Hybrid SPECT-CT With Labeled Leukocytes for Diagnosis of Vascular Prosthesis Infections". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02538133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*